CGH
CVS icon

Crossmark Global Holdings’s CVS Health CVS Stock Holding History

Crossmark Global Holdings’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.9M Buy
395,817
+21,381
+6% +$1.91M 0.53% 37
2026
Q1 		$26.9M Buy
374,436
+5,875
+2% +$453K 0.4% 53
2025
Q4 		$29.2M Sell
368,561
-15,987
-4% -$1.26M 0.42% 47
2025
Q3 		$29M Buy
384,548
+62,305
+19% +$4.27M 0.43% 44
2025
Q2 		$22.2M Buy
322,243
+5,805
+2% +$381K 0.36% 61
2025
Q1 		$21.4M Buy
316,438
+19,913
+7% +$1.19M 0.38% 57
2024
Q4 		$13.3M Sell
296,525
-171,259
-37% -$9.61M 0.24% 96
2024
Q3 		$29.4M Buy
467,784
+50,981
+12% +$2.97M 0.52% 34
2024
Q2 		$24.6M Sell
416,803
-11,173
-3% -$699K 0.47% 36
2024
Q1 		$34.1M Sell
427,976
-17,942
-4% -$1.37M 0.65% 22
2023
Q4 		$35.2M Buy
445,918
+162,296
+57% +$11.6M 0.73% 22
2023
Q3 		$20.3M Buy
283,622
+1,752
+0.6% +$124K 0.46% 39
2023
Q2 		$21M Buy
281,870
+43,760
+18% +$3.11M 0.45% 40
2023
Q1 		$17.7M Sell
238,110
-42,786
-15% -$3.59M 0.42% 50
2022
Q4 		$26.2M Sell
280,896
-109,209
-28% -$10.5M 0.65% 20
2022
Q3 		$37.2M Sell
390,105
-1,289
-0.3% -$128K 1.03% 5
2022
Q2 		$36.3M Buy
391,394
+121,841
+45% +$11.9M 0.94% 9
2022
Q1 		$27.3M Buy
269,553
+7,496
+3% +$787K 0.61% 25
2021
Q4 		$27M Buy
262,057
+47,727
+22% +$4.41M 0.59% 23
2021
Q3 		$18.2M Buy
214,330
+1,520
+0.7% +$127K 0.43% 44
2021
Q2 		$17.8M Sell
212,810
-8,272
-4% -$677K 0.42% 45
2021
Q1 		$16.6M Sell
221,082
-10,764
-5% -$784K 0.41% 46
2020
Q4 		$15.8M Sell
231,846
-117,908
-34% -$7.67M 0.4% 49
2020
Q3 		$20.4M Sell
349,754
-11,888
-3% -$740K 0.57% 27
2020
Q2 		$23.5M Buy
361,642
+111,694
+45% +$7.03M 0.69% 25
2020
Q1 		$14.8M Buy
249,948
+3,229
+1% +$216K 0.53% 33
2019
Q4 		$18.3M Buy
246,719
+144,551
+141% +$10.1M 0.5% 36
2019
Q3 		$6.44M Sell
102,168
-12,473
-11% -$739K 0.19% 136
2019
Q2 		$6.25M Buy
114,641
+2,528
+2% +$136K 0.18% 141
2019
Q1 		$6.05M Sell
112,113
-6,436
-5% -$397K 0.17% 149
2018
Q4 		$7.77M Buy
118,549
+10,629
+10% +$793K 0.24% 105
2018
Q3 		$8.49M Sell
107,920
-6,491
-6% -$464K 0.22% 114
2018
Q2 		$7.36M Buy
114,411
+4,036
+4% +$266K 0.2% 129
2018
Q1 		$6.87M Sell
110,375
-6,474
-6% -$465K 0.18% 141
2017
Q4 		$8.47M Buy
116,849
+8,347
+8% +$607K 0.2% 122
2017
Q3 		$8.82M Buy
+108,502
New +$8.58M 0.23% 108
2016
Q3 		$8.82M Buy
+108,502
New +$10.2M 0.23% 108

Other funds holding CVS

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

Crossmark Global Holdings's CVS Position: Q2 2026 in Review

Crossmark Global Holdings increased its CVS Health (CVS) stake by 5.7% in Q2 2026, buying an estimated $1.91M and bringing the position to 395,817 shares worth $40.9M. The position accounts for 0.53% of the portfolio, ranked #37.

Crossmark Global Holdings first reported a position in CVS in Q3 2016 and has held it in 37 quarters since. 650 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Crossmark Global Holdings held 395,817 shares of CVS Health worth $40.9M as of Q2 2026.
  • Crossmark Global Holdings bought 21,381 CVS Health shares in Q2 2026, an estimated $1.91M.
  • CVS Health made up 0.53% of Crossmark Global Holdings's portfolio in Q2 2026, its #37 holding.
  • Crossmark Global Holdings first reported a position in CVS Health in Q3 2016 and has held it in 37 quarters since.
  • 650 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.